Company intelligence
Infinita
Infinita facilitates access to faster regulatory pathways for novel treatments (e.g. Montana SB 535)
Biotechnology Research
Roatán, HN
11 employees
Founded 2025
2 public signals
About Infinita
Infinita has formed the first-ever ETRB (experimental treatment review board) under Montana law. The review board’s role is oversight for access to treatments before FDA approval. For a $12.5k fee, you can submit a post-phase-1 therapy to our review board: https://www.montanaetrb.org/
Verified activity
Signals from Infinita
2 published signals
Legal & Regulatory
Infinita discussed the Montana SB535 pathway for post phase one treatments through licensed clinics overseen by an independent review board.
Reported by Infinita
Presence & Recognition
Infinita spoke with Tomás Pérez and Treygoff explaining that demand to move or invest in Próspera already exists, but years of political risk made it difficult to finance and build enough real estate to meet it.
Reported by Infinita